Each example is the question as a person would ask it, the tool call the assistant makes, and the answer from the data as of 13 October 2026 (filings through 9 October 2026). Amounts are as filed and rounded.
“Who in California raised money for the first time this year?”
search_private_offerings(state="CA", amendments="new", from_date="2026-01-01")
4,106 new Form D notices were filed by issuers with a California address between 1 January and 9 October 2026 2026. Together they report $102.6 billion sold as filed; the offerings with a stated amount plan $151.5 billion in total, and 1,502 have no fixed amount (filed as Indefinite). The response breaks the total down by SEC's own industry group and fund type:
| Industry group / fund type | Filings | Amount sold |
|---|
| Other Technology | 541 | $39.3B |
| Pooled Investment Fund / Venture Capital Fund | 911 | $21.7B |
| Pooled Investment Fund / Private Equity Fund | 618 | $12.9B |
| Pooled Investment Fund / Other Investment Fund | 541 | $9.0B |
| Other | 419 | $3.8B |
| Insurance | 23 | $3.3B |
| Pooled Investment Fund / Hedge Fund | 123 | $2.7B |
| Biotechnology | 107 | $1.9B |
Adding sort="sold" puts the largest first: X.AI Holdings Corp. ($16.6 billion sold of a $20.0 billion offering, 131 investors, Rule 506(b), filed 6 January), Founders Fund Growth IV ($6.02 billion), Databricks ($5.0 billion, Rule 506(c), filed 27 August), Kleiner Perkins Select Fund IV ($1.92 billion), YCP26 ($1.71 billion), Seidler Equity Partners IX ($1.60 billion) and Baseten Labs ($1.10 billion of $1.5 billion).
“Which venture capital funds raised money this year, and how much?”
search_private_offerings(fund_type="Venture Capital Fund", amendments="new", from_date="2026-01-01", sort="sold")
7,597 new venture capital fund notices in 2026 so far, $46.5 billion sold against $121.4 billion planned (1,314 of them Indefinite). The largest by amount sold:
| Fund | City | Filed | Sold | Offering | Investors |
|---|
| Founders Fund Growth IV, LP | San Francisco, CA | 2026-03-23 | $6.02B | $6.02B | 370 |
| Kleiner Perkins Select Fund IV, LLC | Menlo Park, CA | 2026-04-07 | $1.92B | $1.92B | 153 |
| YCP26, L.P. | Mountain View, CA | 2026-04-27 | $1.71B | Indefinite | 87 |
| Altimeter Premier Growth Expansion Fund, L.P. | Boston, MA | 2026-06-23 | $1.50B | $1.50B | 171 |
| Kleiner Perkins XXII, LLC | Menlo Park, CA | 2026-04-07 | $995.0M | $995.0M | 145 |
| YCA26, L.P. | Mountain View, CA | 2026-04-27 | $727.8M | Indefinite | 87 |
| Eclipse Fund VI, L.P. | Palo Alto, CA | 2026-03-31 | $720.0M | $720.0M | 127 |
| HOF Capital Strategic Opportunities Fund II, L.P. | New York, NY | 2026-08-31 | $708.5M | $1.50B | 39 |
Every one of these claims Rule 506(b) together with Investment Company Act Section 3(c)(7), and Founders Fund Growth IV also 3(c)(1). The same call with fund_type="Private Equity Fund" or "Hedge Fund" answers the question for those.
“How has Databricks raised money over the years?”
search_private_offerings(cik="1587468", amendments="all")
Databricks (CIK 1587468) has filed 20 Form D notices since 2013, from a $15 million offering filed from Berkeley to a $5 billion round in August 2026. Each row is one filing; 13 of the 20 are shown. Amounts, investor counts and exemptions are as filed. Form D gives no valuation and no price per share.
| Filed | Form | Sold | Offering | Investors | Exemption |
|---|
| 2013-09-25 | D | $13.9M | $15.0M | 9 | 506(b) |
| 2017-08-22 | D | $140.0M | $140.0M | 16 | 506(b) |
| 2019-02-07 | D | $250.0M | $250.0M | 16 | 506(b) |
| 2019-11-05 | D | $400.0M | $400.0M | 46 | 506(b) |
| 2021-02-02 | D | $1.00B | $1.00B | 155 | 506(b) |
| 2021-09-15 | D | $1.60B | $1.60B | 168 | 506(b) |
| 2023-09-29 | D | $673.8M | $673.8M | 81 | 506(b) |
| 2023-11-13 | D/A | $684.6M | $1.00B | 91 | 506(c) |
| 2025-01-02 | D | $8.59B | $10.00B | 175 | 506(b) |
| 2025-01-02 | D | $1.57B | $1.57B | 88 | 506(b) |
| 2025-09-23 | D | $955.0M | $1.07B | 124 | 506(c) |
| 2025-12-31 | D | $4.08B | $5.00B | 153 | 506(c) |
| 2026-08-27 | D | $5.00B | $5.00B | 136 | 506(c) |
The filings mix Rule 506(b) and, since 2023, Rule 506(c), which permits general solicitation if every investor is verified as accredited. Counting each offering once, at its latest filing, Databricks reports $25.9 billion sold across 17 offerings. SpaceX (CIK 1181412) answers the same way: 21 filings from 2009 to 2022, 15 offerings, $9.0 billion sold, all from Hawthorne, California, under the same CIK as its later filings.
“How did one offering fill up over time?”
get_private_offering(accession_number="0002135424-26-000010")
A Form D/A restates the whole form with the running total sold, so the amendment chain of one offering is a time series. Blue Owl Real Estate Exchange VI DST, a real estate offering (industry group Other Real Estate, Rule 506(b), minimum investment $250,000), filed its notice on 4 June 2026 and has amended it about every two weeks since. The detail call returns every filing of the offering as offering_history:
| Filed | Form | Total sold | Investors |
|---|
| 2026-06-04 | D | $4.8M | 4 |
| 2026-06-17 | D/A | $14.4M | 10 |
| 2026-07-01 | D/A | $16.8M | 15 |
| 2026-07-14 | D/A | $37.9M | 30 |
| 2026-07-30 | D/A | $42.1M | 40 |
| 2026-08-14 | D/A | $93.8M | 80 |
| 2026-08-28 | D/A | $119.5M | 116 |
| 2026-09-11 | D/A | $158.2M | 155 |
| 2026-09-25 | D/A | $216.1M | 187 |
| 2026-10-09 | D/A | $264.7M | 219 |
The same call lists the 15 sales compensation recipients with their CRD numbers and the states each one solicits in: RBC Capital Markets (CRD 31194), Raymond James Financial Services (6694), Morgan Stanley (149777), Merrill Lynch (7691), and registered representatives of Realized Financial, MML Investor Services, Sanctuary Securities, DFPG Investments, Aurora Securities and Kestra Investment Services. Estimated sales commissions: $20.6 million. Because amendments restate the total, a search returns each offering once, at its latest filing, unless you ask for amendments="all".
“Which private offerings are being sold in Texas by paid placement agents?”
search_private_offerings(solicited_in="TX", amendments="new", from_date="2026-01-01")
3,554 new offerings in 2026 name a paid recipient who solicits in Texas. Form D says where the issuer is and where its paid salespeople solicit, never where the investors live, and an offering with no paid agent never matches this filter. By category:
| Industry group / fund type | Filings | Amount sold |
|---|
| Pooled Investment Fund / Other Investment Fund | 650 | $45.9B |
| Pooled Investment Fund / Private Equity Fund | 1,191 | $28.5B |
| Pooled Investment Fund / Hedge Fund | 390 | $24.4B |
| Insurance | 11 | $8.1B |
| Other Banking and Financial Services | 109 | $5.3B |
| Investing | 168 | $3.0B |
| Pooled Investment Fund / Venture Capital Fund | 89 | $3.0B |
| Other Technology | 75 | $1.7B |
To follow one agent instead, filter by name or FINRA CRD number: search_private_offerings(recipient="7691", amendments="new", from_date="2026-01-01", sort="sold") finds the 49 new offerings of 2026 that name Merrill Lynch (CRD 7691) as a sales compensation recipient: 26 hedge funds, 18 private equity funds, 4 other investment funds and one Other Energy issuer. The largest are Exchange Place: All Cap III LP ($1.43 billion, 336 investors), Belmere Capital Fund LLC ($1.26 billion, 482 investors) and Balbec IGCF VII, L.P. ($930.4 million).
“Which California companies, not funds, raised $10 million or less this year?”
search_private_offerings(state="CA", exclude_industry="Pooled Investment Fund", min_sold=1, max_sold=10000000, amendments="new", from_date="2026-01-01")
1,248 new notices from California issuers outside the Pooled Investment Fund group report between $1 and $10 million sold, $2.65 billion in total. min_sold=1 leaves out the notices filed before any sale. By industry group:
| Industry group | Filings | Amount sold |
|---|
| Other Technology | 344 | $793.9M |
| Other | 296 | $525.5M |
| Biotechnology | 66 | $213.2M |
| Commercial | 70 | $195.1M |
| Residential | 58 | $181.9M |
| Other Real Estate | 51 | $127.7M |
| Other Health Care | 55 | $114.9M |
| Investing | 38 | $88.1M |
At the top of the range: Navigator Medicines (Biotechnology, $10.0 million sold of a $40.0 million offering, 3 investors), Virtualitics (Other Technology, $10.0 million of $15.0 million), Apollomics (Biotechnology, $10.0 million of $10.0 million, 8 investors), Amlogenyx (Biotechnology, $10.0 million of $20.0 million) and Senti Biosciences Holdings (Biotechnology, $10.0 million of $40.0 million). About 82% of filers choose Decline to Disclose for revenue, so amount bounds find small raises more reliably than the revenue range does.